Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-018-0487-7
Full Text
Open PDFAbstract
Available in full text
Date
January 11, 2019
Authors
Publisher
BMJ